These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

939 related items for PubMed ID: 32194871

  • 21. PLGA nanoparticles codeliver paclitaxel and Stat3 siRNA to overcome cellular resistance in lung cancer cells.
    Su WP, Cheng FY, Shieh DB, Yeh CS, Su WC.
    Int J Nanomedicine; 2012; 7():4269-83. PubMed ID: 22904633
    [Abstract] [Full Text] [Related]

  • 22. Anti-tumor efficiency of paclitaxel and DNA when co-delivered by pH responsive ligand modified nanocarriers for breast cancer treatment.
    Yu D, Li W, Zhang Y, Zhang B.
    Biomed Pharmacother; 2016 Oct; 83():1428-1435. PubMed ID: 27592131
    [Abstract] [Full Text] [Related]

  • 23. Green design "bioinspired disassembly-reassembly strategy" applied for improved tumor-targeted anticancer drug delivery.
    Wang R, Gu X, Zhou J, Shen L, Yin L, Hua P, Ding Y.
    J Control Release; 2016 Aug 10; 235():134-146. PubMed ID: 27238442
    [Abstract] [Full Text] [Related]

  • 24. Selective targeting by preS1 domain of hepatitis B surface antigen conjugated with phosphorylcholine-based amphiphilic block copolymer micelles as a biocompatible, drug delivery carrier for treatment of human hepatocellular carcinoma with paclitaxel.
    Miyata R, Ueda M, Jinno H, Konno T, Ishihara K, Ando N, Kitagawa Y.
    Int J Cancer; 2009 May 15; 124(10):2460-7. PubMed ID: 19173297
    [Abstract] [Full Text] [Related]

  • 25. Paclitaxel tumor priming promotes delivery and transfection of intravenous lipid-siRNA in pancreatic tumors.
    Wang J, Lu Z, Wang J, Cui M, Yeung BZ, Cole DJ, Wientjes MG, Au JL.
    J Control Release; 2015 Oct 28; 216():103-10. PubMed ID: 26272765
    [Abstract] [Full Text] [Related]

  • 26. Neovasculature and circulating tumor cells dual-targeting nanoparticles for the treatment of the highly-invasive breast cancer.
    Yao J, Feng J, Gao X, Wei D, Kang T, Zhu Q, Jiang T, Wei X, Chen J.
    Biomaterials; 2017 Jan 28; 113():1-17. PubMed ID: 27794222
    [Abstract] [Full Text] [Related]

  • 27. Cytotoxicity of paclitaxel incorporated in PLGA nanoparticles on hypoxic human tumor cells.
    Jin C, Bai L, Wu H, Song W, Guo G, Dou K.
    Pharm Res; 2009 Jul 28; 26(7):1776-84. PubMed ID: 19384463
    [Abstract] [Full Text] [Related]

  • 28. Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells.
    Zhang F, Wang X, Xu X, Li M, Zhou J, Wang W.
    Eur J Pharm Sci; 2016 Sep 20; 92():11-21. PubMed ID: 27343697
    [Abstract] [Full Text] [Related]

  • 29. Gene/paclitaxel co-delivering nanocarriers prepared by framework-induced self-assembly for the inhibition of highly drug-resistant tumors.
    Wang C, Guan W, Peng J, Chen Y, Xu G, Dou H.
    Acta Biomater; 2020 Feb 20; 103():247-258. PubMed ID: 31846802
    [Abstract] [Full Text] [Related]

  • 30. Co-Administration Of iRGD Enhances Tumor-Targeted Delivery And Anti-Tumor Effects Of Paclitaxel-Loaded PLGA Nanoparticles For Colorectal Cancer Treatment.
    Zhong Y, Su T, Shi Q, Feng Y, Tao Z, Huang Q, Li L, Hu L, Li S, Tan H, Liu S, Yang H.
    Int J Nanomedicine; 2019 Feb 20; 14():8543-8560. PubMed ID: 31802868
    [Abstract] [Full Text] [Related]

  • 31. Co-delivery of paclitaxel and STAT3 siRNA by a multifunctional nanocomplex for targeted treatment of metastatic breast cancer.
    Luo K, Gao Y, Yin S, Yao Y, Yu H, Wang G, Li J.
    Acta Biomater; 2021 Oct 15; 134():649-663. PubMed ID: 34289420
    [Abstract] [Full Text] [Related]

  • 32. Melanin-loaded biocompatible photosensitive nanoparticles for controlled drug release in combined photothermal-chemotherapy guided by photoacoustic/ultrasound dual-modality imaging.
    Wang W, Jing T, Xia X, Tang L, Huang Z, Liu F, Wang Z, Ran H, Li M, Xia J.
    Biomater Sci; 2019 Oct 01; 7(10):4060-4074. PubMed ID: 31475710
    [Abstract] [Full Text] [Related]

  • 33. Low-density lipoprotein-coupled micelles with reduction and pH dual sensitivity for intelligent co-delivery of paclitaxel and siRNA to breast tumor.
    Zhu WJ, Yang SD, Qu CX, Zhu QL, Chen WL, Li F, Yuan ZQ, Liu Y, You BG, Zhang XN.
    Int J Nanomedicine; 2017 Oct 01; 12():3375-3393. PubMed ID: 28490877
    [Abstract] [Full Text] [Related]

  • 34. Human Papillomavirus E6/E7-Specific siRNA Potentiates the Effect of Radiotherapy for Cervical Cancer in Vitro and in Vivo.
    Jung HS, Rajasekaran N, Song SY, Kim YD, Hong S, Choi HJ, Kim YS, Choi JS, Choi YL, Shin YK.
    Int J Mol Sci; 2015 May 29; 16(6):12243-60. PubMed ID: 26035754
    [Abstract] [Full Text] [Related]

  • 35. Co-delivery of hydrophobic paclitaxel and hydrophilic AURKA specific siRNA by redox-sensitive micelles for effective treatment of breast cancer.
    Yin T, Wang L, Yin L, Zhou J, Huo M.
    Biomaterials; 2015 Aug 29; 61():10-25. PubMed ID: 25996409
    [Abstract] [Full Text] [Related]

  • 36. Tumor Selective Silencing Using an RNAi-Conjugated Polymeric Nanopharmaceutical.
    Svenson S, Case RI, Cole RO, Hwang J, Kabir SR, Lazarus D, Lim Soo P, Ng PS, Peters C, Shum P, Sweryda-Krawiec B, Tripathi S, van der Poll D, Eliasof S.
    Mol Pharm; 2016 Mar 07; 13(3):737-47. PubMed ID: 26835715
    [Abstract] [Full Text] [Related]

  • 37. Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation.
    Zhao P, Wang H, Yu M, Liao Z, Wang X, Zhang F, Ji W, Wu B, Han J, Zhang H, Wang H, Chang J, Niu R.
    Eur J Pharm Biopharm; 2012 Jun 07; 81(2):248-56. PubMed ID: 22446630
    [Abstract] [Full Text] [Related]

  • 38. A Photopolymerized Semi-Interpenetrating Polymer Networks-Based Hydrogel Incorporated with Nanoparticle for Local Chemotherapy of Tumors.
    Wang Y, Li Q, Zhou JE, Tan J, Li M, Xu N, Qu F, Chen J, Li J, Wang J, Liang Z, Yu L, Wang Y, Yan Z.
    Pharm Res; 2021 Apr 07; 38(4):669-680. PubMed ID: 33796952
    [Abstract] [Full Text] [Related]

  • 39. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy.
    Guo Y, Wang XY, Chen YL, Liu FQ, Tan MX, Ao M, Yu JH, Ran HT, Wang ZX.
    Acta Biomater; 2018 Oct 15; 80():308-326. PubMed ID: 30240955
    [Abstract] [Full Text] [Related]

  • 40. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo.
    Lu J, Chuan X, Zhang H, Dai W, Wang X, Wang X, Zhang Q.
    Int J Pharm; 2014 Aug 25; 471(1-2):525-35. PubMed ID: 24858391
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 47.